Skip to main content
Clinical Trials/NCT03054142
NCT03054142
Recruiting
Not Applicable

China Collaborative Study on Epidemiology of Acute Kidney Injury

XinLing Liang1 site in 1 country1,000,000 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
XinLing Liang
Enrollment
1000000
Locations
1
Primary Endpoint
Incidence of AKI
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Acute kidney injury (AKI) is a common clinical syndrome, especially patients in the hospital. AKI has become a huge medical burden in China. Little information is available about this disease burden in our country. The investigators aimed to evaluate the burden of AKI and to analyze the related risk factors.

Detailed Description

The investigators launch a nationwide of all patients, who were admitted to hospital from 2011-2016. Patients were diagnosed on the basis of changes in serum creatinine by the laboratory information system. The investigators assessed rates of AKI according to the criteria of 2012 Kidney Disease Improving Global Outcomes (KDIGO).

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
December 31, 2027
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
XinLing Liang
Responsible Party
Sponsor Investigator
Principal Investigator

XinLing Liang

Director of Division of Nephrology and Blood Purification Center of Guangdong General Hospital

Guangdong Provincial People's Hospital

Eligibility Criteria

Inclusion Criteria

  • The patients diagnosed on the basis of changes in serum creatinine according to the criteria of 2012 Kidney Disease Improving Global Outcomes(KDIGO)

Exclusion Criteria

  • Serum creatinine record less than two times during hospitalization
  • Patients being diagnosed with End-stage kidney disease (chronic kidney disease stage 5)
  • Nephrectomy
  • Kidney transplantation
  • Peak serum creatinine of less than 53µ mol/L
  • Serum creatinine decrease after amputation

Outcomes

Primary Outcomes

Incidence of AKI

Time Frame: Jan. 2011 to Oct. 2016

Secondary Outcomes

  • Longer ICU stay(Jan. 2011 to Oct. 2016)
  • In-hospital mortality(Jan. 2011 to Oct. 2016)
  • Recognition rate of AKI(Jan. 2011 to Oct. 2016)
  • Proportion of nephrology referral(Jan. 2011 to Oct. 2016)
  • Higher medical cost(Jan. 2011 to Oct. 2016)

Study Sites (1)

Loading locations...

Similar Trials